Instead, both OPC-14597 and OPC-4392 exhibit clear antagonist actions at postsynaptic receptors ... and may be related to the differing clinical profiles of these two compounds.

The pharmacotherapy of schizophrenia is currently dominated by atypical antipsychotics that primarily ... to selectively modulate muscarinic receptors by targeting the acetylcholine binding ...